Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-04 @ 3:07 PM
Study NCT ID:
NCT02749903
Status:
UNKNOWN
Last Update Posted:
2021-10-26
First Post:
2016-04-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
None
Primary Completion Date:
2019-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-21
First Submit QC Date:
None
Study First Post Date:
2016-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-11
Results First Submit QC Date:
None
Results First Post Date:
2020-01-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-06
Last Update Post Date:
2021-10-26
Last Update Post Date Type:
ACTUAL